Page last updated: 2024-10-23

bumetanide and Premenstrual Syndrome

bumetanide has been researched along with Premenstrual Syndrome in 2 studies

Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.

Research Excerpts

ExcerptRelevanceReference
"Treatment with bumetanide or bromocriptine had no effect on the parameters studied."1.26Body water and weight in patients with premenstrual tension. ( Andersch, B; Andersson, M; Hahn, L; Isaksson, B, 1978)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersch, B2
Hahn, L2
Wendestam, C1
Ohman, R1
Abrahamsson, L1
Andersson, M1
Isaksson, B1

Trials

1 trial available for bumetanide and Premenstrual Syndrome

ArticleYear
Treatment of premenstrual tension syndrome with bromocriptine.
    Acta endocrinologica. Supplementum, 1978, Volume: 216

    Topics: Adult; Bromocriptine; Bumetanide; Clinical Trials as Topic; Drug Evaluation; Estradiol; Female; Foll

1978

Other Studies

1 other study available for bumetanide and Premenstrual Syndrome

ArticleYear
Body water and weight in patients with premenstrual tension.
    British journal of obstetrics and gynaecology, 1978, Volume: 85, Issue:7

    Topics: Adult; Body Water; Body Weight; Bromocriptine; Bumetanide; Female; Humans; Menstruation; Middle Aged

1978